Vitamin D status and erectile function are increasingly discussed together because both intersect with vascular health, endothelial biology, inflammation, and cardiometabolic risk. Erectile function depends on a coordinated sequence of nerve signaling, smooth-muscle relaxation, arterial inflow, and venous occlusion. Vitamin D is not an erectile medication, and deficiency should not be treated as a single-cause explanation for erectile dysfunction. But low serum 25-hydroxyvitamin D has been associated with worse erectile-function scores in several observational studies, especially in men with vascular risk factors or arteriogenic ED.
The clinical question is therefore not whether vitamin D "fixes" ED. The better question is whether vitamin D status can help identify a broader physiologic pattern: endothelial dysfunction, reduced nitric oxide availability, metabolic disease, low physical activity, obesity, poor sleep, or cardiovascular risk. For men with erectile symptoms, that distinction matters. It keeps the discussion evidence-based, avoids cure claims, and places vitamin D testing in the same practical category as blood pressure, A1c, lipids, testosterone assessment when appropriate, and medication review.
Vitamin D Status and Erectile Function Share Vascular Biology
Normal erection is a vascular event initiated by neurologic stimulation. Sexual arousal increases parasympathetic signaling and nitric oxide release in penile tissue. Nitric oxide stimulates cyclic guanosine monophosphate, which relaxes cavernosal smooth muscle and allows blood to fill the corpora cavernosa. Phosphodiesterase type 5 breaks down cyclic guanosine monophosphate, which is why PDE5 inhibitors may support erectile response in men who are medically appropriate candidates.
Vitamin D may influence several parts of this upstream environment. Experimental and clinical literature links vitamin D signaling with endothelial function, nitric oxide synthase activity, vascular inflammation, oxidative stress, insulin sensitivity, and blood pressure regulation. These mechanisms are relevant because endothelial dysfunction can reduce nitric oxide bioavailability before a man ever reaches the medication-response step. If penile arteries are less able to dilate, erectile response may be less reliable even when libido and testosterone are adequate.
This does not make vitamin D deficiency a diagnosis of ED. Serum 25-hydroxyvitamin D is influenced by season, sun exposure, skin pigmentation, adiposity, diet, supplement use, liver and kidney health, and chronic illness. Low vitamin D may be a marker of poor overall health rather than a direct cause in every case. Still, because ED frequently overlaps with cardiometabolic risk, vitamin D status can be clinically relevant when interpreted as part of a full assessment rather than as an isolated target.
What Observational Studies Have Found
The strongest signal connecting vitamin D and ED comes from observational research. A 2019 systematic review and meta-analysis in Andrologia evaluated studies comparing vitamin D levels and erectile-function scores. The authors found that men without vitamin D deficiency had modestly higher IIEF-5 scores than men with deficiency, but they also emphasized heterogeneity and cautioned that the overall evidence did not prove a strong causal relationship.
More recent reviews have reached a similar, more nuanced conclusion. A 2025 systematic review in Journal of Clinical Medicine identified 10 eligible studies involving more than 13,000 men. Across the included observational studies, moderate-to-severe ED and arteriogenic ED were commonly associated with lower serum 25-hydroxyvitamin D. Some analyses reported that vitamin D levels below 20 ng/mL were linked with higher ED prevalence, while higher levels were associated with lower prevalence. However, the review also noted that randomized trial evidence has been inconsistent.
That inconsistency is important. Observational studies can identify associations, but they cannot fully separate cause from correlation. Men with lower vitamin D may also have more obesity, less outdoor activity, worse cardiometabolic health, diabetes, hypertension, depression, sleep disturbance, or medication burden. Each of those factors can independently affect erectile function. A clinically responsible interpretation is that low vitamin D may support a vascular-risk pattern, especially in men with arteriogenic symptoms, but it should not be presented as a stand-alone explanation.
Why Randomized Trial Evidence Is More Cautious
Randomized trials test a different question: if vitamin D is supplemented, does erectile function improve? The answer has not been consistently positive. The largest recent data point is the D-Health Trial analysis published in Clinical Nutrition ESPEN in 2024. In this randomized, placebo-controlled study, 8,920 older men completed the ED assessment after three years of monthly vitamin D supplementation. Serum vitamin D levels rose substantially in the supplementation group, but ED prevalence was essentially unchanged: 58.8% in the vitamin D group and 59.0% in the placebo group.
That result does not mean vitamin D is irrelevant to sexual health. It means broad supplementation of older men, regardless of baseline erectile physiology and without targeting severe deficiency or arteriogenic ED, did not prevent or improve ED in that trial. A man who is deficient may still need correction for bone health, muscle function, immune function, or general medical reasons. But the D-Health findings argue against promising that vitamin D supplementation alone will improve erections.
Smaller interventional studies have suggested possible benefit in selected deficient populations, but these studies are not definitive. Differences in baseline vitamin D level, dose, duration, comorbid disease, concomitant lifestyle change, and ED cause make the literature difficult to generalize. The practical takeaway is measured: testing and correcting deficiency may be reasonable in a broader health plan, while prescription ED treatment, cardiovascular risk management, lifestyle changes, and evaluation for endocrine or medication causes remain central.
Clinical Context: When Vitamin D Testing May Be Useful
Vitamin D testing may be worth discussing with a clinician when ED appears alongside risk factors for deficiency or vascular disease. These include limited sun exposure, darker skin pigmentation in low-sun environments, obesity, malabsorption disorders, chronic kidney or liver disease, older age, low dietary intake, certain medications, diabetes, hypertension, metabolic syndrome, or a history suggesting low physical activity. Testing may also be reasonable when a man has symptoms or risks related to bone health, muscle weakness, or recurrent deficiency.
Interpreting the result requires restraint. Many laboratories classify levels below 20 ng/mL as deficient, with 20 to 29 ng/mL often described as insufficient, though thresholds vary by guideline and clinical context. More is not automatically better. Excessive vitamin D intake can cause hypercalcemia, kidney stones, gastrointestinal symptoms, confusion, and kidney injury. Men should avoid high-dose supplementation without medical supervision, especially if they have kidney disease, granulomatous disease, hyperparathyroidism, or take medications that affect calcium metabolism.
For erectile symptoms specifically, vitamin D should be assessed alongside higher-yield clinical questions. Is blood pressure controlled? Is diabetes present or undiagnosed? Are lipids abnormal? Is the man using nicotine? How much alcohol is consumed? Is sleep apnea likely? Are antidepressants, finasteride, opioids, beta-blockers, or other medications contributing? Are morning erections present? Is libido reduced? Is there pelvic surgery, Peyronie's disease, neurologic disease, depression, or performance anxiety? These questions often reveal the treatable drivers that determine response.
How Vitamin D Fits With ED Treatment Planning
ED treatment works best when it is matched to physiology. For many men, the first-line prescription discussion involves PDE5 inhibitors such as tadalafil, sildenafil, or vardenafil, provided there are no contraindications such as nitrate use. These medications do not create sexual arousal; they support the nitric oxide-cGMP pathway once arousal and vascular signaling are present. That is why vascular health, medication timing, alcohol intake, meal composition, sleep, stress, and endocrine status can all affect perceived response.
Vitamin D correction, when indicated, belongs in the longer-term health layer. It may support endothelial health and cardiometabolic resilience in deficient men, but it should not replace evidence-based ED therapy or cardiovascular evaluation. In practice, a clinician may combine several steps: screen for cardiovascular risk, correct clear deficiency, improve exercise and sleep, reduce heavy alcohol use, manage diabetes or hypertension, and prescribe medication when appropriate. This layered plan is more consistent with the evidence than either ignoring vitamin D entirely or overpromising its effect.
Men should also understand the time scale. PDE5 inhibitors can act within hours depending on the drug. Lifestyle changes and correction of metabolic abnormalities usually take weeks to months. Vitamin D repletion, when needed, also takes time and should be monitored with reasonable dosing rather than aggressive self-treatment. If ED is new, worsening, or accompanied by chest pain, shortness of breath, reduced exercise tolerance, penile pain, curvature, neurologic symptoms, or very low libido, medical evaluation should come before experimentation.
Conclusion
The evidence on vitamin D status and erectile function is clinically interesting but not definitive. Observational studies suggest that low serum 25-hydroxyvitamin D is associated with worse erectile-function scores and may be more common in men with vascular or moderate-to-severe ED. Randomized trial evidence is more cautious, including a large 2024 trial that found no ED benefit from broad vitamin D supplementation in older men. The most responsible conclusion is that vitamin D status may be one useful marker in a vascular and metabolic assessment, not a stand-alone ED treatment.
If you're exploring clinically-formulated options, OnyxMD offers physician-supervised treatment plans, including EPIQ CHEWS, starting with a free online assessment at questionnaire.getonyxmd.com. More evidence-focused articles are available on the /blog.
These statements have not been evaluated by the FDA. This content is for informational purposes only and does not constitute medical advice.
References
- Matukaitiene R, Pikelyte A, Zilaitiene B, Lazauskas R, Verkauskiene R, Ceponis J. The Association Between Vitamin D Levels and Erectile Dysfunction in Men: A Systematic Review. Journal of Clinical Medicine. 2025;14(24):8630. doi:10.3390/jcm14248630
- Crafa A, Cannarella R, Condorelli RA, La Vignera S, Calogero AE. Vitamin D and Male Erectile Function: An Updated Review. International Journal of Molecular Sciences. 2020;21(22):8582. doi:10.3390/ijms21228582
- Barassi A, Pezzilli R, Colpi GM, Corsi Romanelli MM, Melzi d'Eril GV. Vitamin D and erectile dysfunction. The Journal of Sexual Medicine. 2014;11(11):2792-2800. doi:10.1111/jsm.12661
- Wei H, Song Y, Chen L, Li Y. Serum vitamin D levels and erectile dysfunction: A systematic review and meta-analysis. Andrologia. 2019;51(3):e13211. doi:10.1111/and.13211
- Romero BD, Neale RE, Baxter C, et al. The effect of three years of vitamin D supplementation on erectile dysfunction: Results from the randomized placebo-controlled D-Health Trial. Clinical Nutrition ESPEN. 2024;60:109-115. doi:10.1016/j.clnesp.2024.01.011
Medical Disclaimer: The information provided on this website is for educational and informational purposes only and is not intended as medical advice. OnyxMD services should not be used to diagnose, treat, cure, or prevent any disease or medical condition. Always consult with a qualified healthcare provider before beginning any supplement regimen or health program.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Individual Results: Results may vary. The experiences and testimonials presented on this website are individual results that may not be typical. Your experience may be different.
Telehealth Services: OnyxMD provides telehealth services in 47 states (excluding AK, MS, NJ) through licensed healthcare providers via our partner Beluga Health, P.A. Services are subject to clinical evaluation and may not be appropriate for all individuals. Prescriptions fulfilled by Strive Pharmacy LLC (License #99-9817) and EPIQ SCRIPTS LLC.